Few Winners

A public portfolio with real money, since November 2026

Few
Winners

I only invest in companies that share their market with very few rivals, and every month I show whether that beats the S&P 500.

See the shortlistRead the blog

The score

Few Winners against the S&P 500 (via SXR8), start = 100

Few Winners100.0
S&P 500100.0

0.0 pp · Level for now: the portfolio is 100% SXR8 · Updated November 12, 2026 · start November 2, 2026

Allocation

Target
50%40%10%
Now
100%
  • S&P 500 (SXR8)
  • Few winners
  • Future winners

What a few winners look like

Market shares in a few markets I invest in. Two or three players split almost everything.

Credit ratings (outstanding ratings, 2023)Source

S&P 50% · Moody's 32% · Fitch 12% · others 6%

EUV lithography (machines for leading-edge chips)Source

ASML 100%

Chip design software (EDA), top 2 combinedSource

Cadence + Synopsys 85% · others 15%

Industrial gases, top 3 combinedSource

Linde + Air Liquide + Air Products 70% · others 30%

The rules

  1. Quality first

    Monopoly, duopoly or oligopoly. High margins, high return on capital, plenty of free cash flow and revenue that grows every year. Three yeses, or the company is out.

  2. Then the price

    I only buy when the price-to-earnings ratio is at least 15% below the company's own 5-year average. That is the buy zone.

  3. Otherwise: the index

    If nothing is in the buy zone, the monthly deposit goes to the S&P 500. The index wins whenever I see no opportunity.

In the buy zone now

Updated November 12, 2026 · Shortlist →

  • Fair IsaacFICONYSE

    Near-monopoly in US credit scores

    -62%below own average · K/W 15.5 vs 41.2

  • HermèsRMSEuronext Paris

    Top-tier luxury, near-monopoly on Birkin and Kelly

    -42%below own average · K/W 29.0 vs 50.2

  • Booking HoldingsBKNGNasdaq

    Online travel oligopoly with Expedia and Airbnb

    -37%below own average · K/W 13.7 vs 21.9

  • Intuitive SurgicalISRGNasdaq

    Near-monopoly in surgical robots

    -34%below own average · K/W 40.0 vs 60.7

  • SynopsysSNPSNasdaq

    Chip-design software duopoly with Cadence

    -31%below own average · K/W 25.6 vs 37.3

  • MSCIMSCINYSE

    Index oligopoly with S&P and FTSE Russell

    -30%below own average · K/W 28.5 vs 40.5

Latest articles

All articles →